End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,800 KRW | -0.26% | +1.33% | -7.54% |
2023 | Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023. | CI |
2023 | Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index | CI |
Sales 2012 | 102B 74.34M 102M | Sales 2013 | 108B 78.61M 107M | Capitalization | 42.44B 30.86M 42.15M |
---|---|---|---|---|---|
Net income 2012 | -4.85B -3.53M -4.82M | Net income 2013 | 1.42B 1.03M 1.41M | EV / Sales 2012 | 0.48 x |
Net Debt 2012 | 12.68B 9.22M 12.59M | Net Debt 2013 | 6.12B 4.45M 6.08M | EV / Sales 2013 | 0.45 x |
P/E ratio 2012 |
-7.47
x | P/E ratio 2013 |
30
x | Employees | 393 |
Yield 2012 |
2.39% | Yield 2013 |
2.32% | Free-Float | 58.96% |
1 day | -0.26% | ||
1 week | +1.33% | ||
Current month | -1.81% | ||
1 month | -2.94% | ||
3 months | -0.78% | ||
6 months | -5.94% | ||
Current year | -7.54% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 03-02-27 |
Seok-Bong Lee
DFI | Director of Finance/CFO | 67 | 89-05-07 |
Young-Hak Kim
BRD | Director/Board Member | 62 | 07-10-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Han-Gu Lee
CHM | Chairman | 76 | 74-08-08 |
Cheon-Soo Ham
BRD | Director/Board Member | 77 | 99-02-04 |
Sang-Joon Lee
CEO | Chief Executive Officer | 47 | 03-02-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3,800 | -0.26% | 34,677 |
24-04-25 | 3,810 | -1.04% | 32,044 |
24-04-24 | 3,850 | +0.92% | 41,625 |
24-04-23 | 3,815 | +0.66% | 39,491 |
24-04-22 | 3,790 | +1.07% | 33,447 |
End-of-day quote Korea S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-7.54% | 76.41M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A004310 Stock